We found significant differences in Ll-LEAP2 expression levels between the control and infection groups in the skin and intestine (t-test, both P < 0.01), with a 24.7-fold up-regulation in the skin of the infection group, and a 2.6-fold down-regulation in the intestine of the infection group (Fig. 5). Here, LEAP2 is linked to infection.